Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly EBT Margin came in at 493.91% in Q1 2026, down 48168.0% year-on-year from N/an in Q1 2025, and down 14721.61% quarter-over-quarter from 3.33% in Q4 2025.
Mirum Pharmaceuticals (MIRM) EBT Margin (2021 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EBT Margin history runs 6 years deep, the most recent figure standing at 493.91% for Q1 2026.
- On a quarterly basis, EBT Margin fell 48168.0% year-over-year to 493.91% in Q1 2026; TTM through Mar 2026 was 140.0%, a 11999.0% decrease from a year earlier, with the FY2025 full-year figure at 4.11%, up 2169.0% from the prior year.
- EBT Margin slipped to 493.91% in Q1 2026 per MIRM's latest filing, from 3.33% in the prior quarter.
- Across five years, EBT Margin topped out at 1.99% in Q3 2025 and bottomed at 493.91% in Q1 2026.
- The 5-year median for EBT Margin is 48.9% (2023), against an average of 106.16%.
- Biggest YoY gain for EBT Margin was 75192 bps in 2022; the steepest drop was 195580 bps in 2022.
- Year by year, EBT Margin stood at 130.05% in 2022, then soared by 61 bps to 50.94% in 2023, then jumped by 52 bps to 24.51% in 2024, then soared by 86 bps to 3.33% in 2025, then slumped by 14722 bps to 493.91% in 2026.
- Per Business Quant, the three latest MIRM EBT Margin figures stand at 493.91% (Q1 2026), 3.33% (Q4 2025), and 1.99% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -493.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -493.91% |
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | 1.99% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | -12.23% |
| Dec 31, 2024 | -24.51% |
| Sep 30, 2024 | -15.37% |
| Jun 30, 2024 | -30.82% |
| Mar 31, 2024 | -35.62% |
| Dec 31, 2023 | -50.94% |
| Sep 30, 2023 | -48.90% |
| Jun 30, 2023 | -196.61% |
| Mar 31, 2023 | -94.72% |
| Dec 31, 2022 | -130.05% |
| Sep 30, 2022 | -190.06% |
| Jun 30, 2022 | -191.56% |
| Mar 31, 2022 | -283.86% |
| Dec 31, 2021 | 1,825.75% |
| Sep 30, 2021 | -941.98% |
| Jun 30, 2021 | -398.94% |